Lords Mark Unlisted Share Price Description – Lord’s Mark Industries is a growing industrial conglomerate in India, known for its diversified presence across railway traction, cement, steel, petrochemicals, and more. Currently trading as an unlisted company, its shares attract considerable interest from investors exploring opportunities in the unlisted market segment.
This article provides an in-depth analysis of Lord’s Mark unlisted share price, financial performance, market position, and investment outlook as of 2025.
Read Also: Apollo Green Energy Unlisted Share Price
Business Model of Lord’s Mark
Lord’s Mark Industries follows a diversified and sustainable business model centered around three primary business units: Diagnostic and MedTech, LED-Solar, and Paper products. The company aims to establish itself as a globally recognized brand by creating sustainable businesses that deliver value to all stakeholders. Key aspects of the company’s business model include:
- Diagnostics and MedTech: Offering rapid test kits, biochemicals, surgical consumables, and technology-driven health testing machines with expansions into genomic testing. They have around 34 types of rapid test kits and strong R&D partnerships. They have exclusive partnerships with IIT Bombay and BARC for advanced healthcare solutions.
- LED-Solar: Providing smart lighting and solar energy solutions, including rooftop solar projects for government buildings, with plans to deploy 500 MW of solar energy in the coming years.
- Paper and Printing Products: Manufacturing specialized printing papers like computer continuous stationery, railway tickets, and government-registered paper products. This division also includes a market leader in paper printing products.
- Pharmaceuticals & Hygiene Care: Under the LordsMed division, offering pharmaceuticals and hygiene care products and serving as a channel partner for Cipla Healthcare in the government sector.
- Diversification into sister companies such as automotive, insurance, biotech, and micro-biotech to enrich their business portfolio.
- Strong focus on sustainability and technology adoption with plans for expansion, including a solar module plant and increasing MedTech capacity.
Market Confidence via Fundraising
Lords Mark successfully raised INR 31.2 crore in a Series A funding round in February 2025 from investors including Brand Capital and Bennett, Coleman. A planned reverse merger with Kratos Energy is underway as a prelude to going public, with a BSE listing expected within 90–120 days. The company’s ambition is clear: a public offering later in 2025 that should raise another INR 500 crore.
Product Portfolio of Lord’s Mark
- Medical & Surgical Products: Disposable Syringes, Hypodermic Needles, Surgical Blades, IV Cannula, Scalp Vein Set, Three-Way Stopcock, PPE Kit, N95 Masks, Surgical Adhesive Tape.
- Diagnostic Kits: Rapid Test Kits for various medical conditions (multiple types).
- Biotech Products: Protein Powders and Tablets under brand names like Sante & Beaute.
- Paper Products: Computer Continuous Stationery, Railway Tickets, Reservation Charts, Coupons, Postal Acknowledgment Slips.
- LED-Solar Products: Smart LED Lights, Solar Rooftop Systems, Solar Street Lights.
- Pharmaceuticals & Hygiene: LordsMed branded pharmaceutical and hygiene care products.
Read Also: PharmEasy Unlisted Share Price
Key Highlights FY23 – 24
- Lord’s Mark Industries is set to debut on the BSE after merging with Lord’s Mark India, offering a 1:1.25 share swap. With global investor backing and partnerships, the company also targets an NSE listing and worldwide expansion.
- The LED and solar division generated INR 172.2 crore in revenue, with an outstanding order book of INR 1,587 crore, providing medium-term visibility.
- The company executed government contracts across several states and is delivering products for major clients such as Cipla Healthcare.
- Raised INR 31.2 crore in Series A (Feb 2025) and planning a reverse merger with Kratos Energy as a step toward public listing.
- Revenue: Grew from INR 305.60 crore in FY23 to INR 555.22 crore in FY24 — 81.68% growth.
- Net Income: Rose from INR 4.64 crore in FY23 to INR 11.26 crore in FY24 — over 2.4x increase.
- The company’s total outstanding liabilities to adjusted net worth improved to 1.07x in FY 2024 from 1.64x in FY 2023, showcasing strengthened financial health.
- Over 300 products under brands like LordsMed, Lords Zoom, Lords Pavak, SafeSehat, and more.
- Served 200+ clients with 5+ key distribution partnerships, including Braithwaite, Dozee, HAL, KAL, and Philips.
Lord’s Mark Subsidiaries
- Lords Mark Insurance Broking Services
- Lords Mark Organics India
- Lords 21 Network India
- Lords Mark Biotech
- Brahamastra Defence Techno Products
Read Also: Biggest Unlisted Companies in India
Lord’s Mark Board of Directors
- Dr. Sachidanand Upadhyay, CEO & MD
- Mr. Manav Teli, Executive Director
- Mr. Subodh Gupta, Independent Director/ CEO, Lords Micro Biotech
- Mr. Vinod Tiwari, Independent Director
- Mr. Veer Singh, Independent Director / CEO, Lords Automotive
Lord’s Mark Share Price Details
| Name | Lords Mark Unlisted Share Price Details |
| Face Value | INR 5 per share |
| ISIN Code | INE0MPL01010 |
| Lot Size | 500 shares |
| Demat Status | NSDL, CDSL |
| Share Price of Lord’s Mark | INR 107 per share |
| Market Cap | INR 1,931 crores |
| Total number of shares | 18,04,32,313 shares |
| Website | www.lordsmark.com |
Lords Mark Unlisted Share Price – Shareholding Pattern
The details of shareholders’ holding of equity shares:
| Shareholder Name | % to Holding | No. of shares |
| Promoters | 94.86 | 17,11,58,092 |
| Public | 5.14 | 92,74,221 |
Read Also: TATA Technologies Unlisted Share Price
Lords Mark Unlisted Share Price – Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
| Revenue | 213.24 | 305.60 | 555.22 |
| Revenue Growth (%) | 5.75 | 43.31 | 81.68 |
| Expenses | 213.02 | 300.02 | 541.19 |
| Net income | 4.29 | 4.64 | 11.26 |
| Margin (%) | 2.01 | 1.52 | 2.03 |
| ROE (%) | 84.33 | 27.90 | 12.73 |
| EBITDA Margin (%) | 6.14 | 7.26 | 6.84 |
| Debt/Equity | 3.80 | 3.50 | 2.43 |
| EPS | 4.20 | 0.82 | 1.01 |
Read Also: Orbis Financial Unlisted Share Price
Lord’s Mark Unlisted Share Price FAQs
Is it safe to purchase unlisted shares in India?
While there are risks associated with unlisted shares, purchases made from credible brokers and after conducting due diligence considerably lower these risks.
What is Lords Mark unlisted share price?
Lord’s Mark share price today is INR 107 per share. Shares are purchased in lots of 500 shares.
Who determines the Lords Mark unlisted share price?
Lord’s Mark share price is determined by various factors including recent transaction price, supply and demand, valuation in the latest funding round, profitability, and return ratios.
When is Lord’s Mark IPO planned?
Lord’s Mark Industries will debut on the BSE in September 2025 after merging with Lord’s Mark India. The company plans an NSE listing within six months, targeting early 2026, making it a two-step IPO process for wider access and liquidity.